uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
CYP1A2 is more variable than previously thought: a genomic biography of the gene behind the human drug-metabolizing enzyme
Show others and affiliations
2010 (English)In: Pharmacogenetics and genomics, ISSN 1744-6872, Vol. 20, no 11, 647-664 p.Article in journal (Refereed) Published
Abstract [en]

Background and objectives CYP1A2 metabolizes various drugs, endogenous compounds and procarcinogens. As human genetic diversity has been reported to decrease with distance from Ethiopia, we resequenced CYP1A2 in five Ethiopian ethnic groups representing a rough northeast to southwest transect across Ethiopia to establish: (i) what variation exists in comparison with what is already known globally and (ii) what CYP1A2 pharmacogenetic profiles may be present as several CYP1A2-metabolized drugs are administered to Ethiopians. Results and conclusions We found 49 different variable sites (30 of which are novel), nine nonsynonymous changes (seven of which are novel), one synonymous change and 55 different haplotypes, only three of which are previously reported. When haplotypes were constructed using only nonsynonymous polymorphisms to restrict haplotypes to those most likely to affect enzyme structure/function, 10 haplotypes were identified (seven contain previously unidentified nonsynonymous variants and four are predicted to alter the enzyme structure/function). Most individuals have at least one copy of the ancestral haplotype. Comparing these data with those from publically available databases, Ethiopian groups display twice the variation seen in all other populations combined (gene diversity using nonsynonymous variants): Ethiopia = 0.17 +/- 0.02, other populations = 0.08 +/- 0.03. Across the entire gene, Ethiopia also evidences all common variation found on a global scale. We provide evidence of weak purifying selection acting on CYP1A2 and show that the time to most recent common ancestor, calculated using variation in a nearby microsatellite, places several variants into a period predating the expansion of modern humans out of Africa less than 100 000 years ago. Pharmacogenetics and Genomics 20:647-664 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Place, publisher, year, edition, pages
2010. Vol. 20, no 11, 647-664 p.
Keyword [en]
CYP1A2, cytochrome P450 1A2, drug metabolism, Ethiopia, microsatellite, pharmacogenetics, purifying selection, SNPstr, time to most recent common ancestor
National Category
Biological Sciences Medical and Health Sciences
URN: urn:nbn:se:uu:diva-133852DOI: 10.1097/FPC.0b013e32833e90ebISI: 000282965100001OAI: oai:DiVA.org:uu-133852DiVA: diva2:370509
Available from: 2010-11-17 Created: 2010-11-16 Last updated: 2010-11-17Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text
By organisation
Evolutionary Biology
Biological SciencesMedical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 257 hits
ReferencesLink to record
Permanent link

Direct link